APLN and cardiomyopathy: Similarly, previous studies have demonstrated that apelin, the first ligand of APJ, attenuates NLRP3 inflammasome activation in rodent models of acute lung injury, cardiomyopathy, and subarachnoid hemorrhage [36–38].